A biphasic effect of age on CPAP adherence: a cross-sectional study of 26,343 patients.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
27 Sep 2023
Historique:
received: 12 04 2023
accepted: 19 09 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

As the prevalence of OSA increases in older patients, the proportion of elderly patients treated with CPAP is expected to become even higher. We studied CPAP-adherence in a real-life cohort involving a large population of elderly patients with OSA. eQUALISAS is a cross-sectional study of CPAP treated OSA patients for at least 4 months who received remote monitoring during 2021. CPAP adherence, device-reported residual AHI (AHI Data from 26,343 patients including 1656 patients aged [80-85] years and 639 patients aged ≥ 85 years were analysed. Median CPAP adherence increases from 6.3 h (< 50 years) to 7 h (75-80 years) and decreases after this age (p < 0.001). The decrease in CPAP adherence observed after the age of 80 was associated with an increase in the proportion of patients with a CPAP-adherence < 4 h/day (p < 0.001). Proportion of CPAP treated female, patients having AHI This study demonstrates that adherence gradually increases with age until 80 years. The proportion of non-adherent patients grows with age after 80 years old. No significative relationship was found between adherence after 80 years old and gender, leaks and AHI The study is registered on Health Data Hub platform (No. F20220715144543).

Sections du résumé

BACKGROUND BACKGROUND
As the prevalence of OSA increases in older patients, the proportion of elderly patients treated with CPAP is expected to become even higher. We studied CPAP-adherence in a real-life cohort involving a large population of elderly patients with OSA.
METHODS METHODS
eQUALISAS is a cross-sectional study of CPAP treated OSA patients for at least 4 months who received remote monitoring during 2021. CPAP adherence, device-reported residual AHI (AHI
RESULTS RESULTS
Data from 26,343 patients including 1656 patients aged [80-85] years and 639 patients aged ≥ 85 years were analysed. Median CPAP adherence increases from 6.3 h (< 50 years) to 7 h (75-80 years) and decreases after this age (p < 0.001). The decrease in CPAP adherence observed after the age of 80 was associated with an increase in the proportion of patients with a CPAP-adherence < 4 h/day (p < 0.001). Proportion of CPAP treated female, patients having AHI
CONCLUSION CONCLUSIONS
This study demonstrates that adherence gradually increases with age until 80 years. The proportion of non-adherent patients grows with age after 80 years old. No significative relationship was found between adherence after 80 years old and gender, leaks and AHI
TRIAL REGISTRATION BACKGROUND
The study is registered on Health Data Hub platform (No. F20220715144543).

Identifiants

pubmed: 37759266
doi: 10.1186/s12931-023-02543-x
pii: 10.1186/s12931-023-02543-x
pmc: PMC10537927
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

234

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98.
doi: 10.1016/S2213-2600(19)30198-5 pubmed: 31300334 pmcid: 7007763
Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD, Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;05:263–76.
doi: 10.5664/jcsm.27497
Lévy P, Kohler M, McNicholas WT, Barbé F, McEvoy RD, Somers VK, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:15015.
doi: 10.1038/nrdp.2015.15 pubmed: 27188535
Osorio RS, Martínez-García MÁ, Rapoport DM. Sleep apnoea in the elderly: a great challenge for the future. Eur Respir J. 2022;59:2101649.
doi: 10.1183/13993003.01649-2021 pubmed: 34561285
Martinez-Garcia MA, Gozal D. OSA and CPAP treatment in the very elderly: the challenge of the unknown. Sleep. 2021;44:zsab143.
doi: 10.1093/sleep/zsab143 pubmed: 34146096
Sucena M. Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users. Eur Respir J. 2006;27:761–6.
doi: 10.1183/09031936.06.00087705 pubmed: 16585083
Onen F, Onen S-H, Le Vaillant M, Gagnadoux F, Martin F, on behalf of the S.AGES Study Group. Adherence to continuous positive airway pressure treatment in a cohort of elderly adults with newly diagnosed obstructive sleep apnea. Sleep Breath. 2023. https://doi.org/10.1007/s11325-023-02795-3 .
doi: 10.1007/s11325-023-02795-3 pubmed: 36859634
Patel SR, Bakker JP, Stitt CJ, Aloia MS, Nouraie SM. Age and sex disparities in adherence to CPAP. Chest. 2021;159:382–9.
doi: 10.1016/j.chest.2020.07.017 pubmed: 32687910
Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27:1255–73.
doi: 10.1093/sleep/27.7.1255 pubmed: 15586779
Woehrle H, Graml A, Weinreich G. Age- and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med. 2011;12:1034–6.
doi: 10.1016/j.sleep.2011.05.008 pubmed: 22033117
Miner B, Kryger MH. Sleep in the aging population. Sleep Med Clin. 2017;12:31–8.
doi: 10.1016/j.jsmc.2016.10.008 pubmed: 28159095
Gagnadoux F, Le Vaillant M, Goupil F, Pigeanne T, Chollet S, Masson P, et al. Influence of marital status and employment status on long-term adherence with continuous positive airway pressure in sleep apnea patients. PLoS ONE. 2011;6:e22503.
doi: 10.1371/journal.pone.0022503 pubmed: 21857929 pmcid: 3157341
Ødegaard KM, Hallén J, Lirhus SS, Melberg HO, Halvorsen S. Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016. ESC Heart Failure. 2020;7:1917–26.
doi: 10.1002/ehf2.12773 pubmed: 32530563 pmcid: 7373922

Auteurs

Arnaud Prigent (A)

Groupe Médical de Pneumologie, Polyclinique Saint-Laurent, 35000, Rennes, France. dr.arnaudprigent@gmail.com.
Centre du Sommeil Polyclinique Saint Laurent, 35000, Rennes, France. dr.arnaudprigent@gmail.com.

Clément Blanloeil (C)

Elia Medical Ouest, Cesson-Sévigné, France.

Franck Barlet (F)

i-GEIA, Boulogne-Billancourt, France.

Frédéric Gagnadoux (F)

Service de Pneumologie et Médecine du Sommeil, CHU d'Angers, Angers, France.
INSERM, CNRS, MITOVASC, Equipe CarME, SFR ICAT, Université d'Angers, Angers, France.

Dany Jaffuel (D)

Département de Pneumologie, Hôpital Arnaud de Villeneuve, CHRU de Montpellier, Montpellier, France.
Inserm U1046-CNRS 9214-Physiologie et Médecine Expérimentale Cœur et Muscle, Université de Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH